WebMar 30, 2024 · Ted Raad, Chief Executive Officer of Pulmatrix commented, "2024 was a year of significant progress for all of our development programs, setting the stage for significant milestone accomplishments in 2024.In 2024, we completed the Phase 1b study of PUR1800 for acute exacerbations in chronic obstructive pulmonary disease (AECOPD), … WebMay 16, 2024 · Ted Raad will immediately transition from his current role as Chief Business Officer to that of Chief Executive Officer and member of the Pulmatrix Board of Directors. In order to ensure a smooth transition, Dr. Clarke will continue as an advisor to the Board of Directors and Company Management through August 14, 2024.
Rob Reid Speaker TED
WebApr 12, 2024 · Ted op Better Call Saul: Raya Schaduwjaagster op Better Call Saul: Ted op Rozen voor de zwijnen: ‘… oehoeboeroe op Rozen voor de zwijnen: ‘… Martijn Oostra op Raad voor Cultuur: kunst moet… Anneke Goede op Rozen voor de zwijnen. Nog een… petrasparkblog op Interview op Jong Literair… Ted op PostNL weet me te wonen op 42… hadley speech therapy
Pulmatrix Announces Positive Top-Line Data Evaluating …
WebMay 16, 2024 · Mr. Raad brings more than 20 years of experience, including executive leadership roles at Option Care and Sunovion Pharmaceuticals. Mr. Raad earned a BA in Business Administration from the University of Colorado at Boulder and an MBA from the Thunderbird School of Global Management. About Pulmatrix WebMay 3, 2024 · Pulmatrix, Inc. May 03, 2024, 09:50 ET. LEXINGTON, Mass., May 3, 2024 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM) a clinical stage biotechnology company developing inhaled therapies for the ... WebTot 2016 was ik huisarts en -opleider in een groepspraktijk in Amersfoort. Ik deed wetenschappelijk onderzoek en gaf onderwijs in het Julius Centrum van het UMC Utrecht over virale infecties. Ik promoveerde in 1995 op het onderwerp influenza. Zeven jaar was ik lid en plv. voorzitter van de METC van het UMC Utrecht. Thans ben ik lid van de … braintree shooting in mall